Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Blood Biomarkers in Idiopathic Pulmonary Fibrosis
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Purpose
Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease of unknown origin whose incidence has been increasing over the latest decade partly as a consequence of population ageing. New anti-fibrotic therapy including pirfenidone and nintedanib have now proven efficacy in slowing down the disease. Nevertheless, diagnosi...
Alternative Titles
Full title
Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5437192
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5437192
Other Identifiers
ISSN
0341-2040,1432-1750
E-ISSN
1432-1750
DOI
10.1007/s00408-017-9993-5
